Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party Journal Article


Authors: Abou Dalle, I.; Labopin, M.; Khvedelidze, I.; Baron, F.; Brissot, E.; Bug, G.; Esteve, J.; Giebel, S.; Gorin, N. C.; Lanza, F.; Nagler, A.; Peric, Z.; Piemontese, S.; Ruggeri, A.; Sanz, J.; Savani, B.; Schmid, C.; Shouval, R.; Spyridonidis, A.; Versluis, J.; Ciceri, F.; Bazarbachi, A.; Mohty, M.
Article Title: Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party
Keywords: adult; controlled study; middle aged; sorafenib; letter; maintenance therapy; acute leukemia; drug combination; hematopoietic cell; recurrent disease; drug therapy; bone marrow transplantation; allotransplantation; cell transplantation; pharmacology; histogram; allogeneic hematopoietic cell transplantation; clinical outcome; acute myeloid leukemia; human; pharmacoeconomics; venetoclax; enasidenib
Journal Title: Bone Marrow Transplantation
Volume: 60
Issue: 6
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2025-01-01
Start Page: 921
End Page: 923
Language: English
DOI: 10.1038/s41409-025-02576-4
PUBMED: 40229537
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work